Sonnet Biotherapeutics Holdings Inc. buy Chardan Capital
Start price
16.08.23
/
50%
€0.38
Target price
16.08.24
€11.00
Performance (%)
-51.06%
Price
20.11.23
€0.18
Summary
This prediction is currently active. Massive losses of -51.06% have been the result for the BUY prediction by Chardan_Capital. This prediction currently runs until 16.08.24. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sonnet Biotherapeutics Holdings Inc. | - | - |
iShares Core DAX® | 2.594% | -1.861% |
iShares Nasdaq 100 | 3.553% | -2.064% |
iShares Nikkei 225® | 0.687% | -8.704% |
iShares S&P 500 | 2.209% | -1.988% |
Comments by Chardan_Capital for this prediction
In the thread Sonnet Biotherapeutics Hldgs. Inc. diskutieren
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) had its price target lowered by analysts at Chardan Capital from $14.00 to $12.00. They now have a "buy" rating on the stock.
Ratings data for SONN provided by MarketBeat
Stopped prediction by Chardan_Capital for Sonnet Biotherapeutics Holdings Inc.
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
15.02.24
15.02.24
€27.86
15.02.25
15.02.25
-
20.11.23
20.11.23